Total Funding
19
28
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
92186
Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women.
- Zhanna Jumadilova: Chief Clinical Development Officer
Michael Wasserman: Bord of DirectorsPast Role: Advanced Therapeutics, Director of Research
About the Company
Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.
